162 related articles for article (PubMed ID: 27798221)
1. Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients.
Bouazza N; Cressey TR; Foissac F; Bienczak A; Denti P; McIlleron H; Burger D; Penazzato M; Lallemant M; Capparelli EV; Treluyer JM; Urien S
J Antimicrob Chemother; 2017 Feb; 72(2):490-495. PubMed ID: 27798221
[TBL] [Abstract][Full Text] [Related]
2. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
Manfredi R; Calza L
AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
[TBL] [
